Towards a cross-species pharmacology of sensorimotor gating: Effects of amantadine, bromocriptine, pergolide and ropinirole on prepulse inhibition of acoustic startle in rats

Behavioural Pharmacology

Volumn 9, Issue 5-6, 1998, Pages 389-396

  Swerdlow, N R ^a   Taaid, N ^a   Oostwegel, J L ^a   Randolph, E ^a   Geyer, M A ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Amantadine; Bromocriptine; Dopamine; Haloperidol; Olanzapine; Pergolide; Prepulse inhibition; Ropinirole; Schizophrenia; Startle

Indexed keywords

AMANTADINE; BROMOCRIPTINE; NEUROLEPTIC AGENT; PERGOLIDE; ROPINIROLE;

ACOUSTIC REFLEX; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; NEUROCHEMISTRY; NEUROPHYSIOLOGY; NONHUMAN; PREPULSE INHIBITION; RAT; SENSORIMOTOR FUNCTION; STARTLE REFLEX; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0031736368     PISSN: 09558810     EISSN: None     Source Type: Journal    
DOI: 10.1097/00008877-199809000-00002     Document Type: Article

References (45)

1. Abduljawad KAJ, Langley RW, Bradshaw CM, Szabadi E (1997). Evidence for involvement of D2 dopamine receptors in prepulse inhibition of the startle reflex in man [Abstract]. J Psychopharmacol 11:69.
2. Acri JB, Morse DE, Popke EJ, Grunberg NE (1994). Nicotine increases sensory gating measured as inhibition of the acoustic startle reflex in rats. Psychopharmacology 114:369-374.
3. Arnt J, Hyttel J (1985). Differential involvement of dopamine D-1 and D-2 receptors in the circling behaviour induced by apomorphine, SK & F 38393, pergolide and LY 171555 in 6-hydroxydopamine-lesioned rats. Psychopharmacology 85:346-352.
4. Balsara JJ, Dhavare BS, Nandal NV, Chandorkar AG (1983). Effects of 1-histidine and promethazine on apomorphine and amantadine stereotypy in rats. Psychopharmacology 79:372-374.
5. Bolino F, Di Michele V, Di Cicco L, Manna V, Daneluzzo E, Cassachia M (1994). Sensorimotor gating and habituation evoked by electrocutaneous stimulation in schizophrenia. Biol Psychiatry 36:670-679.
6. Braff DL, Stone C, Callaway E, Geyer M, Glick I, Bali L (1978). Prestimulus effects on human startle reflex in normals and schizophrenics. Psychophysiology 15:339-343.
7. Braff DL, Grillon C, Geyer M (1992). Gating and habituation of the startle reflex in schizophrenic patients. Arch Gen Psychiatry 49:206-215.
8. Castellanos FX, Fine EJ, Kaysen DL, Kozuch PL, Hamburger SD, Rapoport JL, Hallett M (1996). Sensorimotor gating in boys with Tourette's Syndrome and ADHD: preliminary results. Biol Psychiatry 39:33-41.
9. Clemens JA, Okimura T, Smalstig EB (1993). Dopamine agonist activities of pergolide, its metabolites, and bromocriptine as measured by prolactin inhibition, compulsive turning, and stereotypic behavior. Arzneimittelforschung 43:281-286.
10. Culpit GC, Temple AR (1984). Gastrointestinal decontamination in the management of the poisoned patient. Emerg Med Clin North Am 2:15-28.
11. Duncan E, Parwani A, Madonick S, Rajan R, Chakravorty S, Efferen T et al. (1997). Ketamine effects on prepulse inhibition of startle in normals. Proc Am Coll Neuropsychopharmacology 299.
12. Eden RJ, Costall B, Domeney AM, Gerrard PA, Harvey CA, Kelly ME et al. (1991). Preclinical pharmacology of ropinirole (SK&F 101468-A) a novel dopamine D2 agonist. Pharmacol Biochem Behav 38:147-154.
13. Feifel D, Swerdlow N (1997). The modulation of sensorimotor gating deficits by mesolimbic cholecystokinin. Neurosci Lett 229:5-8.
14. Graham F (1975). The more or less startling effects of weak prestimuli. Psychophysiology 12:238-248.
15. Hutchison KE, Swift RM (1997). Effects of amphetamine on psychophysiological and subjective measures of stimulation in humans [Abstract]. Proc Soc Psychophysiol Res S45.
16. Jackson DM, Mohell N, Georgiev J, Bengtsson A, Larsson LAG, Magnusson O, Ross SB (1995). Time course of bromocriptine-induced excitation in the rat: behavioural and biochemical studies. Naunyn Schmiedebergs Arch Pharmacol 351:146-155.
17. Kandel ER, Klein M, Castellucci VF, Schacher S, Goelet P (1986). Some principles emerging from the study of short-and long-term memory. Neurosci Res 3:498-520.
18. Karper LP, Grillon C, Charney DS, Krystal JH (1994). The effect of ketamine on prepulse inhibition and attention [Abstract]. Proc Am Coll Neuropsychopharmacology 124.
19. Kornhuber J, Weller M (1993). Amantadine and the glutamate hypothesis of schizophrenia: experiences in the treatment of neuroleptic malignant syndrome. J Neural Transmission 92:57-65.
20. Kornhuber J, Bormann J, Hubers M, Rusche K, Riederer P (1991). Effects of the 1-amino-adamantanes at the MK-801 binding site of the NMDA-receptor gated ion channel: a human post mortem brain study. Eur J Pharmacology 206:297-300.
21. Kumari V, Checkley SA, Gray JA (1996). Effect of cigarette smoking on prepulse inhibition of the acoustic startle reflex in healthy male smokers. Psychopharmacology 128:54-60.
22. Lipinski JF, Sallee FR, Jackson C, Sethuraman G (1997). Dopamine agonist treatment of Tourette disorder in children: results of an open-label trial of pergolide. Movement Disorders 12:402-407.
23. Ljungberg T (1986). Locomotion and stereotyped behaviours induced by 1-amino-3,5-dimethyladamantane (D 145) and apomorphine in the rat: a comparison. J Pharm Pharmacology 38:520-525.
24. Mansbach RS, Geyer MA, Braff DL (1988). Dopaminergic stimulation disrupts sensorimotor gating in the rat. Psychopharmacology 94:507-514.
25. Mansbach RS, Braff DL, Geyer MA (1989). Prepulse inhibition of the acoustic startle response is disrupted by N-ethyl-3,4-methylenedioxyamphetamine (MDEA) in the rat. Eur J Pharmacology 167:49-55.
26. Mizoguchi K, Yokoo H, Yoshida M, Tanaka T, Tanaka M (1994). Amantadine increases the extracellular dopamine levels in the striatum by re-uptake inhibition and by N-methyl-D-aspartate antagonism. Brain Res 662:255-258.
27. Morton N, Ellis C, Gray NS, Toone BK, Leigh PN, Chaudhuri KR (1995). The effects of apomorphine and L-dopa challenge on prepulse inhibition in patients with Parkinson's disease [Abstract]. Schizophrenia Res 15:181.
28. Parker SG, Raval P, Yeulet S, Eden RJ (1994). Tolerance to peripheral, but not central, effects of ropinirole, a selective dopamine D2-like receptor agonist. Eur J Pharmacology 265:17-26.
29. Rasmussen K, Gates MR, Burger JE, Czachura JF (1997). The novel atypical antipsychotic olanzapine, but not the CCK-B antagonist LY288513, blocks apomorphine-induced disruption of pre-pulse inhibition. Neurosci Lett 222:61-64.
30. Rigdon GC, Viik K (1991). Prepulse inhibition as a screening test for potential antipsychotics. Drug Devel Res 23:91-99.
31. Seeman P, Ulpian C, Bergeron C, Riederer P, Jellinger K, Babriel E et al. (1984). Bimodal distribution of dopamine receptor densities in brain of schizophrenics. Science 225:728-731.
32. Snyder SH (1973). Amphetamine psychosis: a 'model' schizophrenia mediated by catecholamines. Am J Psychiatry 130:61-67.
33. Starr MS, Starr BS (1995). Locomotor effects of amantadine in the mouse are not those of a typical glutamate antagonist. J Neural Transmission 9:31-43.
34. Swerdlow NR, Geyer MA (1998). Using an animal model of deficient sensorimotor gating to study the pathophysiology and new treatments of schizophrenia. Schizophr Bull 24:285-302.
35. Swerdlow NR, Geyer M, Braff D, Koob GF (1986). Central dopamine hyperactivity in rats mimics abnormal acoustic-startle in schizophrenics. Biol Psychiatry 21:23-33.
36. Swerdlow NR, Geyer MA, Mansbach R, Braff DL, Pulvirenti L (1990). Amphetamine disrupts prepulse inhibition of acoustic startle in rats: reversal by nucleus accumbens dopamine lesion. Psychopharmacology 100:413-416.
37. Swerdlow NR, Caine SB, Braff DL, Geyer MA (1992). Neural substrates of sensorimotor gating of the startle reflex: preclinical findings and their implications. J Psychopharmacology 6:176-190.
38. Swerdlow NR, Braff DL, Taaid N, Geyer MA (1994). Assessing the validity of an animal model of sensorimotor gating deficits in schizophrenic patients. Arch Gen Psychiatry 51:139-154.
39. Swerdlow NR, Paulsen J, Braff DL, Butters N, Geyer MA, Swenson MR (1995). Impaired prepulse inhibition of acoustic and tactile startle in patients with Huntington's Disease. J Neurol Neurosurg Psychiatry 58:192-200.
40. van Berckel RNM, Oranje B, van Ree, JM, Verbaten MN, Kahn RS (1997). The effects of low dose ketamine on sensory gating, neuroendocrine secretion and behavior in healthy human subjects [Abstract]. Proc Am Coll Neuropsychopharmacology 169.
41. van den Buuse M (1995). Differential effects of quinelorane and pergolide on behaviour, blood pressure, and body temperature of spontaneously hypertensive rats and Wistar-Kyoto rats. Pharmacol Biochem Behav 50:389-397.
42. Vollenweider FX, Liechti M, Gamma A, Hell D, Geyer M (1997). Effects of MDMA ('Ecstasy') on sensorimotor gating, attention, and mood in healthy volunteers. Abstracts: International Congress on the State of the Art in Psychiatry, 19-21 June, Basel, Switzerland, S.28.
43. Wan FJ, Swerdlow NR (1994). Intra-accumbens infusion of quinpirole impairs sensorimotor gating of acoustic startle in rats. Psychopharmacology 113:103-109.
44. Wan FJ, Swerdlow NR (1996). The basolateral amygdala regulates sensorimotor gating of acoustic startle in rats. Neuroscience 76:715-724.
45. Wong D, Wagner H, Tune L, Dannals R, Pearlson G, Links J et al. (1986). Positron emission tomography reveals elevated D2 dopamine receptors in drug-naive schizophrenics. Science 234:1558-1563.